Among them, sitagliptin, vildagliptin, and saxagliptin inhibited the accumulation of Aβ and abnormal phosphorylation of tau to alleviate inflammation and reverse behavioral defects in AD rats [167, 168]. The gene discussed is MAPT; the disease is Alzheimer disease.